HTDI 2024Program

14.15-15.27
Session 6

CLASSIC VS NEW VASCULAR TECHNIQUES

Moderators: Irene Morelli, Andrea Stella

14.16

EDITED VIDEO CASE

Upper arm vascular access for hemodialysis: tips & tricks

Presenter: Matteo Bossi
14.21

Below the knee stenting in chronic limb-threatening ischemia: from bail out to primary strategy

Speaker: Marco Manzi

14.27

Recent advancements in vascular access surgery

Speaker: Matteo Tozzi

14.33

Disease specific stent in the treatment of long SFA occlusion

Speaker: Gianbattista Parlani

14.39

Is there still a role for the chimney technique in pararenal aortic aneurysm?

Speaker: Filippo Benedetto

14.45

Experimental study on a sutureless and clampless side arterio-prosthetic anastomotic device

Speaker: Yves Alimi

14.51

Advantages of new generation fenestrated endografts

Speaker: Sonia Ronchey

14.57

Techniques for orbital atherectomy

Speaker: Mariano Palena

15.03-15.14

Discussion

15.15-15.27

KEYNOTE LECTURE

Janet Powell - A core outcome set for AAA repair

15.30-16.32
Session 7

PERIPHERAL ARTERIAL DISEASE

Moderators: Benjamin Chua, Stefano Pirrelli, Carlo Setacci

15.31

EDITED VIDEO CASE

Open distal and ultra-distal revascularization, including extreme solutions for no option patients

Presenter: Gonçalo Cabral
15.36

The rational of usage of drug eluting technologies: the Catania experience

Speaker: Alessia Giaquinta

15.42

Treatment of pediatric Takayasu disease

Speaker: James Tunnicliffe

15.48

Update on the management of no-option peripheral artery disease

Speaker: Stefano Bartoli

15.54

The end of the smoking era – what next for vascular patients?

Speaker: Michael Jenkins

16.00

Surgical deep vein arterialization for no-option critical limb ischemia patients

Speaker: Francesco Stilo

16.06

36-month update and health economic snapshot Zilverpass Study

Speaker: Gianmarco de Donato

16.12-16.19

Discussion

16.20-16.32

KEYNOTE LECTURE

Eduardo Ramacciotti - Update in anticoagulant and antiplatelet therapy for peripheral arterial disease

16.35-17.37
Session 8

VASCULAR TRAUMA AND OTHER AORTIC TOPICS

Moderators: Luca di Marzo, Paolo Frigatti, Carlos Timaran

16.36

EDITED VIDEO CASE

Update on management of traumatic aortic injury

Presenter: Ali Azizzadeh
16.41

Management of catastrophic iatrogenic vascular injuries in abdominal and pelvic surgery

Speaker: Morad Sallam

16.47

Addressing health inequity with the WARRIORS trial (early EVAR vs surveillance for small AAA in women)

Speaker: Janet Powell

16.53

Is EVAR perioperative mortality the wrong measure of quality? - It's time for a new approach

Speaker: Ian Loftus

16.59

Non atherosclerotic aneurysms

Speaker: Michel S. Makaroun

17.05

Outcomes of leaving the celiac trunk without a stent during 4 vessel fenestrated repair

Speaker: Timothy Resch

17.11

The vascular surgeon in oncologic surgery

Speaker: Pedro Amorim

17.17-17.24

Discussion

17.25-17.37

KEYNOTE LECTURE

Erica Mitchell - Modern management of vascular trauma

17.40-18.52
Session 9

ARTERIAL TOPICS

Moderators: Ronald L. Dalman, Gian Franco Fadda, Arnaldo Ippoliti

17.41

EDITED VIDEO CASE

Thoraco-abdominal aneurysm repair in Oslo

Presenter: Beate R. Lindberg
17.46

A hybrid approach to the treatment of large popliteal artery anuerysms

Speaker: Enrico Ascher

17.52

Improving the outcomes of patients with acute mesenteric ischemia

Speaker: Rabih Chaer

17.58

Endovascular treatment of hostile necks with standard endograft

Speaker: Paolo Frigatti

18.04

Update on randomized trial for SMA stenting of visceral ischemia

Speaker: Timothy Resch

18.10

Risk stratification for SCI after endovascular thoraco-abdominal repair using sarcopenia and AS-score

Speaker: Tilo Kölbel

18.16

Sarcopenia in open aortic abdominal repair

Speaker: Enrico Rinaldi

18.22

F/B-EVAR: choosing the right bridging stent

Speaker: Andrea Kahlberg

18.28

Use off the shelf left subclavian artery branch device for emergencies

Speaker: Steven Maximus

18.34-18.44

Discussion

18.45-18.57

KEYNOTE LECTURE

Hence Verhagen - Dealing with sac growth after EVAR: should we treat Type 2 EL, extend the sealing zone with FEVAR or is there something else going on?